XTLB XTL Biopharmaceuticals
- 2.610
- +0.030+1.16%
- 2.780
- +0.170+6.51%
XTL Biopharmaceuticals News
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 20-F: Registration statement / Annual report / Transition report
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals: FY2022 Annual Report
20-F | XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
XTL Biopharmaceuticals | 6-K/A: Report of foreign private issuer (related to financial reporting)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
XTL Biopharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
XTL Biopharmaceuticals | 20-F: FY2021 Annual Report
Analysis
Price Target
No Data
